1 / 10

Hematologic Cancers Partners Meeting Centers for Disease Control and Prevention May 16, 2008

Hematologic Cancers Partners Meeting Centers for Disease Control and Prevention May 16, 2008. MMRF Background. The MMRF was founded in 1998 by a patient and her identical twin to deliver new treatment options to patients. Educational Focus.

washi
Download Presentation

Hematologic Cancers Partners Meeting Centers for Disease Control and Prevention May 16, 2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hematologic Cancers Partners Meeting Centers for Disease Control and Prevention May 16, 2008

  2. MMRF Background The MMRF was founded in 1998 by a patient and her identical twin to deliver new treatment options to patients.

  3. Educational Focus With four new FDA-approved drugs in the past four years, 20 novel agents, and more than 200 clinical trials, patients and HCPs have numerous questions. MMRF educational efforts address these. Clinical Approaches Revlimid-based regimens Velcade-based regimens Doxil-Velcade Thal-combinations Stem cell transplant Novel agents

  4. Myeloma Background The incidence of myeloma is increasing. Underserved populations continue to be disproportionately affected.

  5. Project Goals The MMRF’s CDC-supported outreach program has the following objectives: • Increase awareness of treatment options and clinical trials among healthcare providers and patients • Improve the reach and effectiveness of patient education strategies • Increase the awareness of MMRF resources among patients and providers

  6. Accomplishments With initial CDC funding, MMRF efforts focused on identifying partners that reach the target population. The VA emerged as the top partner.

  7. Accomplishments The MMRF is the first and only organization to distribute educational materials through the VA system. With positive initial results, the partnership continues to grow.

  8. Evaluation The MMRF evaluates key metrics related to volume monthly. Online surveys with key partners are planned for Q2 2008.

  9. Sustainability To sustain the program, the MMRF must cultivate and expand its current partnerships and identify new partners to continue reach to target population.

  10. Memorable Moment “Through MIVA, the MMRF provided patient and provider educational toolkits to the 170 VA medical centers. The kits provided both audiences with information tailored to their needs…This was the first time that the VA embarked on such a comprehensive disease-specific effort, and I believe this program could serve as a model for other diseases that are commonly seen in the veteran population.” - Thakor G. Patel, MD, Former Program Chief, Renal Diseases, Diabetes and Oncology at the Veterans Health Administration

More Related